The question is, thus, whatever the normal biological function of neuroglobin, how can those cells which contain neuroglobin supress acute apoptotic initiation, during events such as stroke associated hypoxia, whilst, at the same time, avoid the unwanted consequence of apoptotic suppression ,namely chronic promotion of tumour formation, at these sites? The gene discussed is NGB; the disease is Stroke.